Global Point of Care
Faktum är att enbart Abbott levererar över en miljard tester varje år över hela världen.
Exempel: HIV-patienter som testades med en patientnära enhet fick antiretroviral (ART) behandling 130 dagar snabbare än de patienter som diagnostiserats genom analys i ett traditionellt laboratorium.1
Ett typexempel: Hjärtsviktspatienter som genomgick ett patientnära test skrevs ut tre dagar tidigare än de som testades med konventionella metoder, vilket förbättrar både det ekonomiska resultatet och behandlingsresultat. 2
Läs om hur Abbott diagnostiska testlösningar bidrar till att lösa några av de stora problemen inom sjukvården globalt – inklusive de utmaningar som du står inför.
A LEADER IN RAPID POINT-OF-CARE DIAGNOSTICS.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.